AEGERION PHARMACEUTICALS INC's ticker is AEGR and the CUSIP is 00767E102. A total of 101 filers reported holding AEGERION PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $3,756,000 | -58.6% | 198,001 | -42.9% | 0.09% | -87.3% |
| Q1 2015 | $9,081,000 | +16.6% | 347,001 | -6.7% | 0.70% | -88.7% |
| Q4 2014 | $7,790,000 | -47.8% | 372,001 | -16.8% | 6.22% | +258.3% |
| Q3 2014 | $14,921,000 | +4.0% | 447,001 | 0.0% | 1.74% | -98.3% |
| Q2 2014 | $14,344,000 | -37.5% | 447,001 | -10.1% | 100.00% | +855.5% |
| Q1 2014 | $22,952,000 | -40.9% | 497,001 | -9.1% | 10.47% | +129.5% |
| Q4 2013 | $38,815,000 | -35.8% | 547,001 | -22.4% | 4.56% | -9.0% |
| Q3 2013 | $60,479,000 | +8.8% | 705,300 | -19.7% | 5.01% | +84.4% |
| Q2 2013 | $55,600,000 | – | 877,800 | – | 2.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,637,455 | $42,852,000 | 9.04% |
| Broadfin Capital, LLC | 2,502,578 | $65,492,000 | 5.10% |
| SCOPIA CAPITAL MANAGEMENT LP | 5,349,840 | $140,005,000 | 3.03% |
| HighVista Strategies LLC | 265,110 | $6,938,000 | 1.11% |
| Perceptive Advisors | 381,100 | $9,973,000 | 0.78% |
| Healthcare Value Capital, LLC | 25,000 | $654,000 | 0.71% |
| ADVENT INTERNATIONAL, L.P. | 347,001 | $9,081,000 | 0.70% |
| Birchview Capital, LP | 46,000 | $1,204,000 | 0.63% |
| NORTH TIDE CAPITAL, LLC | 300,000 | $7,851,000 | 0.59% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 2,323,633 | $60,809,000 | 0.35% |